2021-04-14 12:05:31 GMT2021-04-14 20:05:31(Beijing Time) Xinhua English
LHASA, April 14 (Xinhua) A national platform for research and promotion of virus diagnosis was officially launched on Wednesday in southwest China s Tibet Autonomous Region.
The platform was established by the National Clinical Research Center for Respiratory Disease and Guangzhou KingMed Diagnostics Group Co., Ltd. It aims to integrate resources, improve diagnostic capacity at the grassroots level and promote the development of data sharing.
The Tibetan Medicine Hospital of the Tibet Autonomous Region is the first hospital that has gained access to the platform. Such a high-level platform will play a positive role in further improving the clinical diagnosis and treatment of respiratory virus infection and upgrading the diagnostic technique of respiratory virus in a laboratory at our hospital, said Padma Yangdron, head of the hospital. Enditem
National virus diagnosis platform settles in China s Tibet shanghaisun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shanghaisun.com Daily Mail and Mail on Sunday newspapers.
Research and Markets: Global Clinical In Vitro Diagnostic Medical Laboratory Services Market Strategies & Trends Report 2021 with Q12021 Update of COVID-19 Impacts - ResearchAndMarkets.com
ResearchAndMarkets.com s offering.
The Clinical Laboratory has seen steady growth for the last 20 years, but this is changing with the effect of the COVID pandemic on healthcare and economic activity. Worse still, Point of Care and Self Testing are threatening long term demand. Understand the opportunities and the threats in this comprehensive report.
The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report from Howe Sound Research. A range of dynamic trends are pushing market growth and company valuations.